Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:27 pm Purchase |
2024-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI |
Armistice Capital, LLC | 4,997,275 9.990% |
4,997,275 (New Position) |
Filing History |
| 2024-12-18 8:19 pm Purchase |
2024-11-25 | 13G | BioXcel Therapeutics, Inc. BTAI |
Oaktree Capital Group Holdings GP LLC | 170,255 5.200% |
170,255 (New Position) |
Filing History |
| 2024-12-18 5:20 pm Purchase |
2024-11-25 | 13G | BioXcel Therapeutics, Inc. BTAI |
Qatar Investment Authority | 170,255 5.200% |
170,255 (New Position) |
Filing History |
| 2024-09-10 10:47 am Sale |
2024-09-09 | 13G | BioXcel Therapeutics, Inc. BTAI |
FMR LLC | 67,208 2.639% |
-90,203 (-57.30%) |
Filing History |
| 2024-06-06 8:29 pm Sale |
2024-06-06 | 13D | BioXcel Therapeutics, Inc. BTAI |
BioXcel LLC | 551,914 23.500% |
-42,126 (-7.09%) |
Filing History |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | BioXcel Therapeutics, Inc. BTAI |
FMR LLC | 157,410 8.603% |
-11,385 (-6.74%) |
Filing History |
| 2024-02-07 07:27 am Sale |
2023-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI |
ADAGE CAPITAL PARTNERS GP L.L.C. | 29,086 1.550% |
-67,701 (-69.95%) |
Filing History |
| 2023-10-19 4:48 pm Unchanged |
2023-09-19 | 13G | BioXcel Therapeutics, Inc. BTAI |
BioXcel Holdings Inc. | 556,359 30.100% |
0 (Unchanged) |
Filing History |
| 2023-10-13 4:01 pm Sale |
2023-10-09 | 13G | BioXcel Therapeutics, Inc. BTAI |
FMR LLC | 168,795 9.227% |
-93,919 (-35.75%) |
Filing History |
| 2023-10-10 09:09 am Purchase |
2023-10-09 | 13G | BioXcel Therapeutics, Inc. BTAI |
FIL Limited | 168,795 9.227% |
168,795 (New Position) |
Filing History |
| 2023-09-28 5:00 pm Sale |
2023-09-19 | 13D | BioXcel Therapeutics, Inc. BTAI |
BioXcel LLC | 594,040 32.500% |
-15,823 (-2.59%) |
Filing History |
| 2023-04-04 06:00 am Sale |
2023-04-03 | 13G | BioXcel Therapeutics, Inc. BTAI |
BioXcel Holdings Inc. | 556,359 30.300% |
-34,395 (-5.82%) |
Filing History |
| 2023-02-14 4:36 pm Purchase |
2022-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI |
BioXcel Holdings Inc. | 590,755 32.700% |
8,376 (+1.44%) |
Filing History |
| 2023-02-13 7:09 pm Sale |
2023-02-14 | 13G | BioXcel Therapeutics, Inc. BTAI |
ALLIANCEBERNSTEIN L.P. | 2,471 0.100% |
-90,627 (-97.35%) |
Filing History |
| 2023-02-09 09:02 am Sale |
2023-01-31 | 13G | BioXcel Therapeutics, Inc. BTAI |
BlackRock Inc. BLK |
82,025 4.700% |
-9,407 (-10.29%) |
Filing History |
| 2023-02-09 08:23 am Purchase |
2023-02-09 | 13G | BioXcel Therapeutics, Inc. BTAI |
FMR LLC | 262,715 14.999% |
399 (+0.15%) |
Filing History |
| 2023-02-03 12:10 pm Purchase |
2022-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI |
BlackRock Inc. BLK |
91,433 5.200% |
91,433 (New Position) |
Filing History |
| 2023-02-02 4:45 pm Purchase |
2023-01-23 | 13G | BioXcel Therapeutics, Inc. BTAI |
ADAGE CAPITAL PARTNERS GP L.L.C. | 96,787 5.530% |
96,787 (New Position) |
Filing History |
| 2022-02-14 4:57 pm Sale |
2021-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI |
BioXcel Holdings Inc. | 582,378 32.400% |
-19,809 (-3.29%) |
Filing History |
| 2022-02-14 4:02 pm Purchase |
2022-02-14 | 13G | BioXcel Therapeutics, Inc. BTAI |
ALLIANCEBERNSTEIN L.P. | 93,098 5.400% |
93,098 (New Position) |
Filing History |